0001437749-23-012870.txt : 20230505
0001437749-23-012870.hdr.sgml : 20230505
20230505193542
ACCESSION NUMBER: 0001437749-23-012870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230504
FILED AS OF DATE: 20230505
DATE AS OF CHANGE: 20230505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Steinhart Richard I
CENTRAL INDEX KEY: 0001293789
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 23895524
MAIL ADDRESS:
STREET 1: 125 ELM STREET
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-05-04
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001293789
Steinhart Richard I
C/O ATOSSA THERAPEUTICS, INC.,
107 SPRING STREET
SEATTLE
WA
98104
1
0
Stock Option (right to buy)
0.662
2023-05-04
4
A
0
125000
0
A
2033-05-04
Common Stock
125000
125000
D
The options shall vest on a quarterly basis over the next 12 months. The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023.
/s/ Richard I. Steinhart
2023-05-05